BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30084650)

  • 21. The alleviation of acute and chronic kidney injury by human Wharton's jelly-derived mesenchymal stromal cells triggered by ischemia-reperfusion injury via an endocrine mechanism.
    Du T; Cheng J; Zhong L; Zhao XF; Zhu J; Zhu YJ; Liu GH
    Cytotherapy; 2012 Nov; 14(10):1215-27. PubMed ID: 22920838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-34 mediates acute kidney injury and worsens subsequent chronic kidney disease.
    Baek JH; Zeng R; Weinmann-Menke J; Valerius MT; Wada Y; Ajay AK; Colonna M; Kelley VR
    J Clin Invest; 2015 Aug; 125(8):3198-214. PubMed ID: 26121749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial dysfunction and the AKI-to-CKD transition.
    Jiang M; Bai M; Lei J; Xie Y; Xu S; Jia Z; Zhang A
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1105-F1116. PubMed ID: 33073587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal ischemia-reperfusion injury causes hypertension and renal perfusion impairment in the CD1 mice which promotes progressive renal fibrosis.
    Greite R; Thorenz A; Chen R; Jang MS; Rong S; Brownstein MJ; Tewes S; Wang L; Baniassad B; Kirsch T; Bräsen JH; Lichtinghagen R; Meier M; Haller H; Hueper K; Gueler F
    Am J Physiol Renal Physiol; 2018 May; 314(5):F881-F892. PubMed ID: 29357437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute Kidney Injury to Chronic Kidney Disease Transition.
    Fiorentino M; Grandaliano G; Gesualdo L; Castellano G
    Contrib Nephrol; 2018; 193():45-54. PubMed ID: 29393158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA hypermethylation in hyperhomocysteinemia contributes to abnormal extracellular matrix metabolism in the kidney.
    Pushpakumar S; Kundu S; Narayanan N; Sen U
    FASEB J; 2015 Nov; 29(11):4713-25. PubMed ID: 26224753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced proliferation and differentiation of HO-1 gene-modified bone marrow-derived mesenchymal stem cells in the acute injured kidney.
    Liu N; Wang H; Han G; Cheng J; Hu W; Zhang J
    Int J Mol Med; 2018 Aug; 42(2):946-956. PubMed ID: 29749549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heme oxygenase-1 induction contributes to renoprotection by G-CSF during rhabdomyolysis-associated acute kidney injury.
    Wei Q; Hill WD; Su Y; Huang S; Dong Z
    Am J Physiol Renal Physiol; 2011 Jul; 301(1):F162-70. PubMed ID: 21511696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Penehyclidine Hydrochloride Pretreatment Ameliorates Rhabdomyolysis-Induced AKI by Activating the Nrf2/HO-1 Pathway and Alleviating [corrected] Endoplasmic Reticulum Stress in Rats. The.
    Zhao W; Huang X; Zhang L; Yang X; Wang L; Chen Y; Wang J; Wu G
    PLoS One; 2016; 11(3):e0151158. PubMed ID: 26987113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression of Chronic Kidney Disease After Acute Kidney Injury: Role of Self-Perpetuating Versus Hemodynamic-Induced Fibrosis.
    Picken M; Long J; Williamson GA; Polichnowski AJ
    Hypertension; 2016 Oct; 68(4):921-8. PubMed ID: 27550923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization of the transition from acute to chronic kidney injury following ischemia/reperfusion.
    Liu J; Kumar S; Dolzhenko E; Alvarado GF; Guo J; Lu C; Chen Y; Li M; Dessing MC; Parvez RK; Cippà PE; Krautzberger AM; Saribekyan G; Smith AD; McMahon AP
    JCI Insight; 2017 Sep; 2(18):. PubMed ID: 28931758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute Kidney Injury: Tubular Markers and Risk for Chronic Kidney Disease and End-Stage Kidney Failure.
    Tan HL; Yap JQ; Qian Q
    Blood Purif; 2016; 41(1-3):144-50. PubMed ID: 26764483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylation in pericytes after acute injury promotes chronic kidney disease.
    Chou YH; Pan SY; Shao YH; Shih HM; Wei SY; Lai CF; Chiang WC; Schrimpf C; Yang KC; Lai LC; Chen YM; Chu TS; Lin SL
    J Clin Invest; 2020 Sep; 130(9):4845-4857. PubMed ID: 32749240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrotic Changes Mediating Acute Kidney Injury to Chronic Kidney Disease Transition.
    Ó hAinmhire E; Humphreys BD
    Nephron; 2017; 137(4):264-267. PubMed ID: 28595180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HO-1 mitigates acute kidney injury and subsequent kidney-lung cross-talk.
    Rossi M; Delbauve S; Roumeguère T; Wespes E; Leo O; Flamand V; Le Moine A; Hougardy JM
    Free Radic Res; 2019 Oct; 53(9-10):1035-1043. PubMed ID: 31530210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholemic Nephropathy Causes Acute Kidney Injury and Is Accompanied by Loss of Aquaporin 2 in Collecting Ducts.
    Bräsen JH; Mederacke YS; Schmitz J; Diahovets K; Khalifa A; Hartleben B; Person F; Wiech T; Steenbergen E; Großhennig A; Manns MP; Schmitt R; Mederacke I
    Hepatology; 2019 May; 69(5):2107-2119. PubMed ID: 30633816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis.
    Chen DQ; Feng YL; Chen L; Liu JR; Wang M; Vaziri ND; Zhao YY
    Free Radic Biol Med; 2019 Apr; 134():484-497. PubMed ID: 30716432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.
    Hu MC; Shi M; Gillings N; Flores B; Takahashi M; Kuro-O M; Moe OW
    Kidney Int; 2017 May; 91(5):1104-1114. PubMed ID: 28131398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined iron sucrose and protoporphyrin treatment protects against ischemic and toxin-mediated acute renal failure.
    Zager RA; Johnson AC; Frostad KB
    Kidney Int; 2016 Jul; 90(1):67-76. PubMed ID: 27165818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant Long-Acting Thioredoxin Ameliorates AKI to CKD Transition via Modulating Renal Oxidative Stress and Inflammation.
    Nishida K; Watanabe H; Murata R; Tokumaru K; Fujimura R; Oshiro S; Nagasaki T; Miyahisa M; Hiramoto Y; Nosaki H; Imafuku T; Maeda H; Fukagawa M; Maruyama T
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.